Skip to content
Screener

R&D at other companies

Polaryx Therapeutics, Inc. logo
Polaryx Therapeutics, Inc.PLYX
$679K-85.6%
Schering-Plough logo
Schering-PloughSGP
$8.54M+41.1%
Deere & Company logo
Deere & CompanyDE
$583M+6.2%
Roblox logo
RobloxRBLX
$422M+12.8%
Salesforce logo
SalesforceCRM
$1.63B+11.4%
Analog Devices logo
Analog DevicesADI
$509.32M+15.3%

Segments

By segment

See full
Europe and ROW$5.07M+25.9%
North America$1.63M+172%

Other financials

Income statement

See full
Revenue$455.5M+82.8%
Gross profit$87.4M+63.9%
Operating income$15.4M+6.8%
Net income$695.0K-66.5%
EPS (diluted)$0.01-80.0%

Balance sheet

See full
Cash & equivalents$115.9M+142%
Total debt$794.1M+52.8%
Total equity$814.7M+119%
Total assets$2.0B+79.7%

Cash flow

See full
Operating cash flow-$17.7M+33.2%
CapEx$1.9M-37.8%
Free cash flow-$19.7M+33.7%

Valuation

See full
Market cap$988.2M+14.5%
Enterprise value$1.67B
P/E118.2×
P/S0.6×

Profitability

See full
Gross margin19.5%-1.2pp
Operating margin4.3%-1.6pp
Net margin0.5%-1.7pp
FCF margin3.3%+2.8pp

Returns & leverage

See full
Return on equity1.4%-5.3pp
Debt / equity-0.4×
Current ratio-0.1×

Where this comes from

Reported directly by Aebi Schmidt Holding in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The source filing: Aebi Schmidt Holding’s 10-Q, filed May 14, 2026.

Filed
May 14, 2026, 7:00 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-034785
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Cost of products sold(368,156)(195,880)
Gross profit87,38953,306
Operating expenses:
Research and development(6,701)(4,627)
Selling, general and administrative(58,547)(30,724)
Amortization of purchased intangibles(8,052)(3,574)
Other operating income1,27913
Total operating expenses(72,021)(38,912)

Item 1. Financial Statements.

FAQ

What is Aebi Schmidt Holding's R&D?
Aebi Schmidt Holding (AEBI) reported R&D of $6.7M in Q1 2026.
How has Aebi Schmidt Holding's R&D changed year-over-year?
Aebi Schmidt Holding's R&D increased by 44.8% year-over-year, from $4.63M to $6.7M.
What is the long-term trend for Aebi Schmidt Holding's R&D?
Over 2 years (2023 to 2025), Aebi Schmidt Holding's R&D has grown at a 24.4% compound annual growth rate (CAGR), from $17.13M to $26.49M.
What does R&D mean?
Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Ask your AI about Aebi Schmidt Holding's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude